We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Steroids in fluid and/or vasoactive infusion dependent pediatric shock: study protocol for a randomized controlled trial.
- Authors
O'Hearn, Katharine; McNally, Dayre; Choong, Karen; Acharya, Anand; Wong, Hector R.; Lawson, Margaret; Ramsay, Tim; McIntyre, Lauralyn; Gilfoyle, Elaine; Tucci, Marisa; Wensley, David; Gottesman, Ronald; Morrison, Gavin; Menon, Kusum; Canadian Critical Care Trials Group
- Abstract
<bold>Background: </bold>Physicians often administer corticosteroids for the treatment of fluid and vasoactive infusion dependent pediatric shock. This use of corticosteroids is controversial, however, and has never been studied in a pediatric randomized controlled trial (RCT). This pilot trial will determine the feasibility of a larger RCT on the role of corticosteroids in pediatric shock.<bold>Methods/design: </bold>Steroids in Fluid and/or Vasoactive Infusion Dependent Pediatric Shock (STRIPES) is a pragmatic, seven-center, double-blind, pilot RCT. We aim to randomize 72 pediatric patients with fluid and vasoactive infusion dependent shock to receive either hydrocortisone or a saline placebo for 7 days or until clinical stability, whichever occurs first. The primary outcome of this pilot trial is the feasibility of recruitment, defined as the number of patients enrolled over a 1-year period. Secondary outcomes include the frequency of, and reasons for, open-label steroid use, protocol adherence, incidence of mortality and corticosteroid-associated adverse events, time to discontinuation of inotropes, and feasibility of blood sampling.<bold>Discussion: </bold>Corticosteroids are used for the treatment of pediatric shock without sufficient evidence to support this practice. While there is a scientific rationale and limited data supporting their use in this setting, there is also evidence from other populations suggesting potential harm. The STRIPES pilot study will assess the feasibility of a larger, much needed trial powered for clinically important outcomes.<bold>Trial Registration: </bold>ClinicalTrials.gov: NCT02044159.
- Subjects
CANADA; STEROID drugs; SHOCK (Pathology); HORMONE therapy; ADRENOCORTICAL hormones; RANDOMIZED controlled trials; HYDROCORTISONE; DRUG side effects; THERAPEUTICS; AGE distribution; COMBINED modality therapy; COMPARATIVE studies; EXPERIMENTAL design; FLUID therapy; INTRAVENOUS therapy; RESEARCH methodology; MEDICAL cooperation; RESEARCH protocols; RESEARCH; RESEARCH funding; STATISTICAL sampling; SEPTIC shock; TIME; VASOCONSTRICTORS; PILOT projects; EVALUATION research; TREATMENT effectiveness; BLIND experiment; PARENTERAL infusions; DIAGNOSIS
- Publication
Trials, 2016, Vol 17, p1
- ISSN
1745-6215
- Publication type
journal article
- DOI
10.1186/s13063-016-1365-6